Gene Therapy Stocks List

Gene Therapy Stocks Recent News

Date Stock Title
May 10 MGTX MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
May 10 MRVI Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 MGTX MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)
May 10 NGNE Neurogene GAAP EPS of -$1.00 beats by $0.03
May 10 NGNE Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
May 9 MRVI Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
May 9 MRVI Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 9 MGTX MeiraGTx GAAP EPS of -$0.32, revenue of $0.69M
May 9 LXEO Lexeo Therapeutics reports Q1 results
May 9 MGTX MeiraGTx Reports First Quarter 2024 Financial and Operational Results
May 9 LXEO Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
May 9 MRVI Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
May 9 GNPX Genprex co-founder, CEO passes away
May 9 MRVI Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
May 9 MRVI Maravai LifeSciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 9 MRVI Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript
May 8 GNPX Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
May 8 MRVI Maravai LifeSciences Holdings GAAP EPS of -$0.09 misses by $0.04, revenue of $64.2M beats by $3.65M
May 8 MRVI Maravai LifeSciences Reports First Quarter 2024 Financial Results
May 8 KRYS Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags